OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 372 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 231

Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Min’an Zhao, Jiayi Chu, Shiyao Feng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114985-114985
Open Access | Times Cited: 130

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Manlian Zhu, Xia Liu, Yiru Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 107

Desulfovibrio in the Gut: The Enemy within?
Sudha Singh, Amanda Carroll‐Portillo, Henry C. Lin
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1772-1772
Open Access | Times Cited: 91

Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 86

Commensal cow Roseburia reduces gut-dysbiosis-induced mastitis through inhibiting bacterial translocation by producing butyrate in mice
Caijun Zhao, Lijuan Bao, Min Qiu, et al.
Cell Reports (2022) Vol. 41, Iss. 8, pp. 111681-111681
Open Access | Times Cited: 73

The gut-brain vascular axis in neuroinflammation
Sara Carloni, María Rescigno
Seminars in Immunology (2023) Vol. 69, pp. 101802-101802
Open Access | Times Cited: 59

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 47

Targeting the gut microbiota-related metabolites for osteoporosis: The inextricable connection of gut-bone axis
Yuan‐Wei Zhang, Yan Wu, Xiang-Fei Liu, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102196-102196
Closed Access | Times Cited: 40

Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Yuanyuan Ma, Xin Li, Jin‐Tai Yu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 21

Short‐chain fatty acids: bridges between diet, gut microbiota, and health
Ling‐Yun Wang, Lihong He, Lijun Xu, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 9, pp. 1728-1736
Open Access | Times Cited: 20

The communication mechanism of the gut-brain axis and its effect on central nervous system diseases: A systematic review
Shengwen Lu, Qiqi Zhao, Yu Guan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117207-117207
Closed Access | Times Cited: 18

Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature
Ana Isabel Beltrán-Velasco, Manuel Reiriz, Sara Uceda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3010-3010
Open Access | Times Cited: 17

Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
Bang-rong Wei, Yujia Zhao, Yufeng Cheng, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 16

The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis
Ruyi Zhang, Ning Ding, X. Feng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 4

Indoleamine 2, 3-dioxygenase 1 inhibition mediates the therapeutic effects in Parkinson's disease mice by modulating inflammation and neurogenesis in a gut microbiota dependent manner
Chen-Meng Qiao, Xiaoyu Ma, Lulu Tan, et al.
Experimental Neurology (2025) Vol. 385, pp. 115142-115142
Closed Access | Times Cited: 2

Interactions of non-starch polysaccharides with the gut microbiota and the effect of non-starch polysaccharides with different structures on the metabolism of the gut microbiota: A review
Yujiao Sun, Jun Yao, Rui Gao, et al.
International Journal of Biological Macromolecules (2025) Vol. 296, pp. 139664-139664
Closed Access | Times Cited: 2

Therapeutic role of gut microbiota in lung injury-related cognitive impairment
Yanxia Cheng, Guangtao Hu, Lin Deng, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 2

Polystyrene microplastics exacerbated liver injury from cyclophosphamide in mice: Insight into gut microbiota
Siyue Wen, Yu Zhao, Shanji Liu, et al.
The Science of The Total Environment (2022) Vol. 840, pp. 156668-156668
Closed Access | Times Cited: 54

Microplastics-perturbed gut microbiota triggered the testicular disorder in male mice: Via fecal microbiota transplantation
Siyue Wen, Yu Zhao, Shanji Liu, et al.
Environmental Pollution (2022) Vol. 309, pp. 119789-119789
Closed Access | Times Cited: 49

Page 1 - Next Page

Scroll to top